The Effect of Subcutaneous Brodalumab upon Clinical Disease Activity in Hidradenitis Suppurativa: An Open Label Cohort Study
Published: 01-05-2020| Version 1 | DOI: 10.17632/98pmyyz67m.1
Contributor:
Description
Supplementary Material
Supplementary Material